1. Home
  2. TSN vs ROIV Comparison

TSN vs ROIV Comparison

Compare TSN & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tyson Foods Inc.

TSN

Tyson Foods Inc.

HOLD

Current Price

$65.46

Market Cap

21.6B

ML Signal

HOLD

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$28.19

Market Cap

20.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSN
ROIV
Founded
1935
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Meat/Poultry/Fish
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.6B
20.7B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
TSN
ROIV
Price
$65.46
$28.19
Analyst Decision
Buy
Strong Buy
Analyst Count
10
8
Target Price
$66.90
$27.56
AVG Volume (30 Days)
2.5M
4.2M
Earning Date
05-04-2026
05-28-2026
Dividend Yield
3.12%
N/A
EPS Growth
N/A
N/A
EPS
0.24
N/A
Revenue
$54,441,000,000.00
$29,053,000.00
Revenue This Year
$5.63
N/A
Revenue Next Year
$1.13
$878.32
P/E Ratio
$272.48
N/A
Revenue Growth
2.12
N/A
52 Week Low
$50.56
$9.87
52 Week High
$66.24
$30.33

Technical Indicators

Market Signals
Indicator
TSN
ROIV
Relative Strength Index (RSI) 64.46 54.52
Support Level $61.99 $26.45
Resistance Level $66.24 $30.33
Average True Range (ATR) 1.27 0.94
MACD 0.38 0.02
Stochastic Oscillator 99.52 80.38

Price Performance

Historical Comparison
TSN
ROIV

About TSN Tyson Foods Inc.

Tyson Foods is a protein-focused food producer, selling raw chicken, beef, pork, and prepared foods. Chicken and beef are its two largest segments, composing about 40% and 30% of sales, respectively. Prepared foods constituted 18% of fiscal 2025 sales and include brands like Tyson, Jimmy Dean, Hillshire Farm, Ball Park, and Sara Lee. However, most of these are in product categories rife with competition where Tyson does not have a massive market share lead. Tyson sells some products overseas, but the international segment accounts for just 4% of total revenue. The company is an active acquirer, with more recent years' purchases focused on international and food-service markets.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: